Hematopoietic Cell Transplantation for Adult Patients With Myelodysplastic Syndromes and Myeloproliferative Disorders Martin Benesch, MD, H. Joachim Deeg, MD Mayo Clinic Proceedings Volume 78, Issue 8, Pages 981-990 (August 2003) DOI: 10.4065/78.8.981 Copyright © 2003 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 1 Impact of International Prognostic Scoring System (IPSS) on outcome of patients with myelodysplastic syndromes. The “+” indicates censored patient; in 7 patients, an IPSS score could not be assigned. Top, Relapse-free survival. Bottom, Cumulative incidence of relapse. Reprinted with permission from Deeg et al.42 Mayo Clinic Proceedings 2003 78, 981-990DOI: (10.4065/78.8.981) Copyright © 2003 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 2 Outcome of patients with myeloproliferative disorders after hematopoietic cell transplantation according to the Lille score. Reprinted with permission from Guardiola et al.49 Mayo Clinic Proceedings 2003 78, 981-990DOI: (10.4065/78.8.981) Copyright © 2003 Mayo Foundation for Medical Education and Research Terms and Conditions